Biocompatibles first-half sales quadruple:
This article was originally published in Clinica
In the first half of the year, UK-based Biocompatibles quadrupled its sales compared with the previous year. Turnover was £1.7 million ($2.6 million), up from £415,000, largely due to the inclusion of £1.4 million in sales from US subsidiary Lombard Lenses which was acquired in September 1994. Net loss rose to £3.7 million from £1 million, which Biocompatibles attributes to the expansion of activities, particularly the commercial development of the eye care and cardiovascular divisions. At its April float on the London market, Biocompatibles raised £17.5 million gross.